STAR THERAPEUTICS
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
STAR THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.star-therapeutics.com
Total Employee:
11+
Status:
Active
Contact:
8887421338
Email Addresses:
[email protected]
Total Funding:
190 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Global Site Tag Organization Schema
Similar Organizations
Big Health
Big Health is a digital therapeutics company operating a healthcare portal to offer behavioral programs for mental health issues.
Disc Medicine
Disc Medicine is a hematology company
Expressable
Expressable is an online speech therapy practice for those with a communication disorder.
Rupa Health
Rupa Health is a telehealth solution that makes it easier to practice root cause medicine.
SamaCare
SamaCare works with manufacturer's medically administered products to optimize prior authorization process while remaining in compliance.
TeleVet
TeleVet is a telemedicine platform that connects veterinarians to their existing clients through an online portal.
Traya Health
Traya Health offers a treatment platform that targets hair loss through a combination of Ayurvedic medicine, nutrition and allopathy.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series C - Star Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Star Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series C - Star Therapeutics
Agent Capital
Agent Capital investment in Series C - Star Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Star Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series C - Star Therapeutics
Qatar Investment Authority
Qatar Investment Authority investment in Series C - Star Therapeutics
Westlake Village BioPartners
Westlake Village BioPartners investment in Series C - Star Therapeutics
NYBC Ventures
NYBC Ventures investment in Series C - Star Therapeutics
Catalio Capital Management
Catalio Capital Management investment in Series C - Star Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-03 | Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer |
Official Site Inspections
http://www.star-therapeutics.com Semrush global rank: 9.01 M Semrush visits lastest month: 445
- Host name: 21.90.145.34.bc.googleusercontent.com
- IP address: 34.145.90.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Star Therapeutics"
Leadership - STAR Therapeutics
Sandip is the Chief Scientific Officer of Star Therapeutics. He started his drug-hunting experience as a scientist at Roche in biochemical pharmacology, and then as a member of the inflammation/ autoimmune group, where he began …See details»
Star Therapeutics - Crunchbase Company Profile
When was the last funding round for Star Therapeutics? Star Therapeutics closed its last funding round on Sep 5, 2023 from a Series C round. Who are Star Therapeutics 's competitors? Alternatives and possible competitors to Star …See details»
Star Therapeutics - LinkedIn
Star Therapeutics is a clinical stage biotechnology company discovering and developing best-in-class antibodies to create life-changing therapies for patients, initially addressing unmet needs in ...See details»
Star Therapeutics - Contacts, Employees, Board Members
Organization. Star Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of …See details»
Our Approach - STAR Therapeutics
Our team applies creativity to expedite clinical development. We take action to quickly validate a scientific idea and achieve rapid proof-of-concept. We strategically discover and select high-potential antibody therapeutics with the …See details»
Star Therapeutics - Crunchbase Company Profile & Funding
Star Therapeutics provides personalized therapy for children. They provide home-based intervention, social skills groups, interdisciplinary team approach, individualized treatment …See details»
Home - Star Therapeutics
Your go-to therapy center for childhood development. Our staff of professional, experienced therapists, provide specialized therapy and behavior plans tailor-made to each individual child. With our state of the art facilities and programs, …See details»
Star Therapeutics Raises $90 Million Financing to …
Sep 5, 2023 For more information, please visit Star Therapeutics and follow us on Twitter @STAR_Biotech and LinkedIn. Contacts Media Contact Kathryn Morris, The Yates Network LLC 914-204-6412 kathryn ...See details»
Investors shower Star Therapeutics with $90M series C
Sep 5, 2023 Investors have showered Star Therapeutics with $90 million to grow its portfolio companies and develop new antibody drugs for diseases with high unmet need. | The latest financing will in part go ...See details»
Star Therapeutics emerges with plans to treat rare diseases …
Feb 16, 2022 But Star Therapeutics, a nearly four-year-old biotechnology startup that unveiled itself Wednesday, hopes to shed more light on these disorders and, ultimately, develop …See details»
Star Therapeutics emerges from stealth mode raising $100M in …
Feb 16, 2022 SOUTH SAN FRANCISCO, CA, February 16, 2022 – Star Therapeutics has emerged from stealth mode today to reveal its pioneering approach to drug discovery and …See details»
Star Therapeutics launches Vega, growing its galaxy of drug startups
Dec 6, 2022 The latest company in Star Therapeutics’ universe of biotech offshoots debuted on Tuesday with plans to develop a drug for a common and chronic blood disorder. Vega …See details»
Star Therapeutics adds another $90M to grow its galaxy of drug …
Sep 5, 2023 Star Therapeutics, a biotechnology company building a group of single-drug startups, has raised $90 million to fund and grow its portfolio of subsidiaries. Some of the …See details»
Backed by $100M, Star Therapeutics sets out to find ... - MedCity …
Feb 16, 2022 Star Therapeutics aims to develop drugs for rare diseases, many of which currently have no FDA-approved treatments. The company forms startups focused on …See details»
STAR IN THE NEWS - star-therapeutics.com
Sep 5, 2023 Star Therapeutics Inc. brought on board six new investors in its oversubscribed $90 million series C round, raising the company’s total funding to more than $190 million since its …See details»
Star Therapeutics emerges from stealth mode raising $100M in …
Feb 16, 2022 Star Therapeutics has formed a family of companies, and Electra Therapeutics is the first to be spun out with a lead monoclonal antibody in Phase 1 clinical development …See details»
Star Therapeutics raises $90m in funding to advance antibody …
Sep 5, 2023 Star’s portfolio consists of two companies: Vega Therapeutics and Electra Therapeutics. Both are developing antibody therapies for treating rare diseases . Vega’s …See details»
Fate Therapeutics Announces Leadership Transition - Morningstar
1 day ago Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular …See details»
Our Pipeline - STAR Therapeutics
Star Therapeutics’ Rich Pipeline of Best-In-Class Antibodies for Serious Hematology and Immunology Diseases Vega Therapeutics is focused on developing novel therapies to address …See details»
News - STAR Therapeutics
Sep 5, 2023 Star Therapeutics, which created two antibody-focused biotech startups with more in the works, has now reeled in a $90 million Series C. The round, disclosed Tuesday morning, …See details»